References
- Sadiq SA, Downes RN. A clinical algorithm for the management of facial nerve palsy from an oculoplastic perspective. Eye (Lond) 1998;12:219–223
- Adams GG, Kirkness CM, Lee JP. Botulinum toxin A induced protective ptosis. Eye (Lond) 1987;1:603–608
- Naik MN, Gangopadhyay N, Fernandes M, et al. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Eye (Lond) 2008;22:1132–1136
- Heyworth PL, Lee JP. Persisting hypotropias following protective ptosis induced by botulinum neurotoxin. Eye (Lond) 1994;8:511–515
- Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 1988;95:473–480
- Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis. Clin Experiment Ophthalmol 2001;29:394–399